Causal discovery and inference in COVID-19: A multiscale longitudinal analysis using mixtures of DAGs
PLOS One · 30.10.2026 · 21 (10) · e0355553
DOI: 10.1371/journal.pone.0355553 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 30.10.2026. Verfasst von Kosar Abdollahi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics, School of Mathematics, Statistics and Computer Science, College of Science, University of Tehran, Tehran, Iran. Hauptthemen laut MEDLINE: COVID-19, Coronavirus Infections, Pneumonia, Viral. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iran National Science Foundation.
Abstract (Originalsprache)
Real-world longitudinal clinical datasets present major challenges for causal discovery due to mixed variable types, temporal dependencies, treatment-selection mechanisms, missingness, and patient heterogeneity. We extended the Causal Inference over Mixtures (CIM) framework to accommodate mixed-type longitudinal data and applied it to 1,937 hospitalized patients from the Khorshid COVID Cohort. The analysis integrated admission characteristics, symptom trajectories, in-hospital treatments, laboratory measures, and short-term outcomes up to 12 weeks after discharge using mixed conditional-independence testing, bootstrap stability selection, graph-based interpretation, and follow-up outcome assessment. The recovered ancestral structures revealed clinically coherent symptom clusters at admission and persistent associations among several post-discharge symptoms, including cough, fatigue/weakness, shortness of breath, weight loss, and loss of smell. Treatment-related associations were interpreted cautiously because cumulative treatment exposure may reflect disease severity, hospitalization duration, physician decision-making, and other selection mechanisms. In particular, the observed associations involving ceftriaxone and interferon- β should be regarded as exploratory and require independent validation. Simulation studies demonstrated that CIM consistently outperformed PC, FCI, RFCI, and CCI, achieving the highest recovery accuracy and balanced accuracy while maintaining low false-positive rates and competitive computational efficiency, even in the presence of latent confounding and selection bias. These results support the feasibility and utility of the proposed framework for identifying robust structural patterns in complex longitudinal clinical data. Given the observational nature of the study, the single-cohort design, and the absence of external replication, the findings should be viewed primarily as hypothesis-generating rather than confirmatory evidence of causal effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Statistics, School of Mathematics, Statistics and Computer Science, College of Science, University of Tehran, Tehran, Iran.
- Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.
ORCID-Profile: Zahra Rezaei Ghahroodi
Förderung
- Iran National Science Foundation
Zitieren
APA
Abdollahi, K., Rezaei Ghahroodi, Z., & Mansourian, M. (2026). Causal discovery and inference in COVID-19: A multiscale longitudinal analysis using mixtures of DAGs. PLOS One, 21(10), e0355553. https://doi.org/10.1371/journal.pone.0355553
Vancouver
Abdollahi K, Rezaei Ghahroodi Z, Mansourian M. Causal discovery and inference in COVID-19: A multiscale longitudinal analysis using mixtures of DAGs. PLOS One. 2026;21(10):e0355553. doi:10.1371/journal.pone.0355553
BibTeX
@article{Abdollahi2026,
author = {Abdollahi, Kosar and Rezaei Ghahroodi, Zahra and Mansourian, Marjan},
title = {Causal discovery and inference in COVID-19: A multiscale longitudinal analysis using mixtures of DAGs},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {10},
pages = {e0355553},
doi = {10.1371/journal.pone.0355553}
}
EUVIMED